Literature DB >> 6019351

Three years' experience with bypass cannulae for chronic hemodialysis.

W J Keon, R Mangel, M Kaye.   

Abstract

In 14 patients over the past three years, "bypass" cannulae have been inserted to relieve obstruction in cannulae used for chronic hemodialyses. Experience with these patients has prompted changes resulting in improved technique.Clotting was the major cause of cannulae failure and infection was the second most important cause. Other causes of failure included: venous atheroma, cannulae extrusion, aneurysms of the vessel at the cannulae tips, obstructive vegetation on the vessel wall, calcium deposits on the vessel wall, and thrombi on the vein walls.The mean survival time was improved from 1.9 months in 1963-1964 to over 9.0 months in 1965-1966. The longest surviving cannula set was two years and the shortest one week.It is considered that the most important factors contributing to increased cannula survival are improved cannula care by patients and staff, the use of angiography for accurate diagnosis, and prompt anticoagulation if atheromatous stenosis of the venous component is encountered.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6019351      PMCID: PMC1936026     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  2 in total

1.  Eight months' experience with silastic-teflon bypass cannulas.

Authors:  W E QUINTON; D H DILLARD; J J COLE; B H SCRIBNER
Journal:  Trans Am Soc Artif Intern Organs       Date:  1962

2.  Chronic hemodialysis for terminal renal failure.

Authors:  A G Shimizu; M Kaye; B J Innes
Journal:  Can Med Assoc J       Date:  1966-02-12       Impact factor: 8.262

  2 in total
  2 in total

1.  Surgical technique for creation of an arteriovenous fistula using a looped bovine graft.

Authors:  E A Lefrak; G P Noon
Journal:  Ann Surg       Date:  1975-12       Impact factor: 12.969

2.  Treatment of clotting in arterial hemodialysis cannulae with CA-7, a fibrinolytic enzyme from Aspergillus oryzae.

Authors:  A W Perry
Journal:  Can Med Assoc J       Date:  1968-04-20       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.